Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews · asked by two or more reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

All‐cause mortality · people with sickle cell disease

Summary of findings ‐ Hydroxyurea showed no clear difference in death during the study (all deaths) compared with placebo (moderate certainty).

1 finding from 1 review · compare the 2 reviews

Hydroxyurea (hydroxycarbamide) for sickle cell disease 2022 · Cochrane Headline outcomes only
RR 0.65 [0.19, 2.27]
5 studies · 784 participants
Moderate